Literature DB >> 20511705

Transcriptomic analysis of mild hypothermia-dependent alterations during endothelial reperfusion injury.

Dan Yang1, Yong Zeng, Cui Tian, Jing Liu, Shu-Bin Guo, Yue-Hong Zheng, Hui-Hua Li.   

Abstract

BACKGROUND: Mild hypothermia (32-34 degrees C) improves resistance to ischemia-reperfusion (I/R) injury. However, the mechanisms by which it affects human cellular function are not fully elucidated. To further test for hypothermic modulation of global biological processes, we used DNA microarray technique to detect the overall gene expression profile.
METHODS: Human umbilical endothelial cells (HUVECs) were incubated under control condition (37 degrees C) or mild hypothermia (33 degrees C) for 2 hours after stimulated ischemia. Detection of differentially expressed genes was performed with Affymetrix U133 plus 2.0 arrays and PARTEK software. We used DAVID and KEGG Pathways database to identify global trends in gene expression data.
RESULTS: Our analysis has identified numerous interesting genes and processes that are differentially presented in hypothermic group when compared with normothermic control. The cell cycle was the most prominent process; several genes involved in cell apoptosis and proliferation displayed significantly differential expression; lower transcriptional level was observed for genes involved in chemokine and cell adhesion processes; genes associated with activity of transmembrane transporter and lipase were also under-expressed.
CONCLUSION: Our data indicated that mild hypothermia altered endothelial expression pattern under the condition of I/R, preferably through varying the expression of genes associated with cell cycle, apoptosis, proliferation, and inflammatory response. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511705     DOI: 10.1159/000315079

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Implication for long-term hypothermia on degradation of interleukin-8 mRNA in endothelial cells stimulated with lipopolysaccharides.

Authors:  Atsushi Sakurai; Kosaku Kinoshita; Makoto Furukawa; Akihiro Noda; Jumko Yamaguchi; Rikimaru Kogawa; Katsuhisa Tanjoh
Journal:  Ther Hypothermia Temp Manag       Date:  2012-06       Impact factor: 1.286

2.  Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.

Authors:  Yuan Zhang; Yu-Ming Kang; Cui Tian; Yong Zeng; Li-Xin Jia; Xu Ma; Jie Du; Hui-Hua Li
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

3.  Circulating E3 ligases are novel and sensitive biomarkers for diagnosis of acute myocardial infarction.

Authors:  Qiu-Yue Han; Hong-Xia Wang; Xiao-Hong Liu; Cai-Xia Guo; Qi Hua; Xiao-Hong Yu; Nan Li; Yan-Zong Yang; Jie Du; Yun-Long Xia; Hui-Hua Li
Journal:  Clin Sci (Lond)       Date:  2015-06       Impact factor: 6.124

4.  Local cryotherapy minimally impacts the metabolome and transcriptome of human skeletal muscle.

Authors:  Dylan C Sarver; Kristoffer B Sugg; Nathaniel P Disser; Elizabeth R Sibilsky Enselman; Tariq M Awan; Christopher L Mendias
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

5.  Time Series Gene Expression Profiling and Temporal Regulatory Pathway Analysis of Angiotensin II Induced Atrial Fibrillation in Mice.

Authors:  Yu-Xuan Wu; Xiao Han; Chen Chen; Lei-Xin Zou; Zhi-Chao Dong; Yun-Long Zhang; Hui-Hua Li
Journal:  Front Physiol       Date:  2019-05-29       Impact factor: 4.566

6.  Transcriptional effects of E3 ligase atrogin-1/MAFbx on apoptosis, hypertrophy and inflammation in neonatal rat cardiomyocytes.

Authors:  Yong Zeng; Junjie Li; Hong-Xia Wang; Shu-Bin Guo; Hui Yang; Xiang-Jun Zeng; Quan Fang; Chao-Shu Tang; Jie Du; Hui-Hua Li
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

7.  Molecular and cellular pathways as a target of therapeutic hypothermia: pharmacological aspect.

Authors:  Hyung Soo Han; Jaechan Park; Jong-Heon Kim; Kyoungho Suk
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.